{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:03:48Z","timestamp":1779858228024,"version":"3.53.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"DOI":"10.7759\/cureus.109707","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:34:41Z","timestamp":1779856481000},"source":"Crossref","is-referenced-by-count":0,"title":["Metabolic and Inflammatory Markers of Fatty Liver As Associated Factors of Hepatic Metastatic Spread in Colorectal Cancer"],"prefix":"10.7759","author":[{"given":"Syed Umar","family":"Farooq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Sameer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umair","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena Kumari","family":"Sunil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010040","article-title":"Colorectal cancer: current updates and future perspectives","volume":"13","author":"Marcellinaro R","year":"2023","unstructured":"Marcellinaro R, Spoletini D, Grieco M, et al.. Colorectal cancer: current updates and future perspectives. J Clin Med. 2023, 13:40. 10.3390\/jcm13010040","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-249. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061679","article-title":"Colorectal cancer liver metastases: genomics and biomarkers with focus on local therapies","volume":"15","author":"Kitsel Y","year":"2023","unstructured":"Kitsel Y, Cooke T, Sotirchos V, Sofocleous CT. Colorectal cancer liver metastases: genomics and biomarkers with focus on local therapies. Cancers (Basel). 2023, 15:1679. 10.3390\/cancers15061679","journal-title":"Cancers (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem E","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, et al.. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016, 27:1386-1422. 10.1093\/annonc\/mdw235","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-024-00934-z","article-title":"Mechanisms of metastatic colorectal cancer","volume":"21","author":"Ca\u00f1ellas-Socias A","year":"2024","unstructured":"Ca\u00f1ellas-Socias A, Sancho E, Batlle E. Mechanisms of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol. 2024, 21:609-625. 10.1038\/s41575-024-00934-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease \u2014\u00a0meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi ZM","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease \u2014\u00a0meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016, 64:73-84. 10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17132539","article-title":"Prognostic factors in colorectal liver metastases: an exhaustive review of the literature and future prospectives","volume":"17","author":"Conticchio M","year":"2025","unstructured":"Conticchio M, Uldry E, H\u00fcbner M, et al.. Prognostic factors in colorectal liver metastases: an exhaustive review of the literature and future prospectives. Cancers. 2025, 17:2539. 10.3390\/cancers17132539","journal-title":"Cancers"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg H","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010, 52:1836-1846. 10.1002\/hep.24001","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13536","article-title":"Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B","volume":"32","author":"Chan AW","year":"2017","unstructured":"Chan AW, Wong GL, Chan HY, et al.. Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B. J Gastroenterol Hepatol. 2017, 32:667-676. 10.1111\/jgh.13536","journal-title":"J Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20078","article-title":"Diabetes and cancer: a consensus report","volume":"60","author":"Giovannucci E","year":"2010","unstructured":"Giovannucci E, Harlan DM, Archer MC, et al.. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010, 60:207-221. 10.3322\/caac.20078","journal-title":"CA Cancer J Clin"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer","volume":"88","author":"Guthrie GJ","year":"2013","unstructured":"Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013, 88:218-230. 10.1016\/j.critrevonc.2013.03.010","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm E","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007, 370:1453-1457. 10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2023.102363","article-title":"Age-related differences in colon and rectal cancer survival by stage, histology, and tumour site: an analysis of United States SEER-18 data","volume":"84","author":"Pilleron S","year":"2023","unstructured":"Pilleron S, Withrow DR, Nicholson BD, Morris EJ. Age-related differences in colon and rectal cancer survival by stage, histology, and tumour site: an analysis of United States SEER-18 data. Cancer Epidemiol. 2023, 84:102363. 10.1016\/j.canep.2023.102363","journal-title":"Cancer Epidemiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3925-x","article-title":"Colorectal cancer liver metastase \u2014 a population-based study on incidence, management and survival","volume":"18","author":"Engstrand J","year":"2018","unstructured":"Engstrand J, Nilsson H, Str\u00f6mberg C, Jonas E, Freedman J. Colorectal cancer liver metastase \u2014 a population-based study on incidence, management and survival. BMC Cancer. 2018, 18:78. 10.1186\/s12885-017-3925-x","journal-title":"BMC Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.827019","article-title":"Combined effect of healthy lifestyle factors and risks of colorectal adenoma, colorectal cancer, and colorectal cancer mortality: systematic review and meta-analysis","volume":"12","author":"Yu J","year":"2022","unstructured":"Yu J, Feng Q, Kim JH, Zhu Y. Combined effect of healthy lifestyle factors and risks of colorectal adenoma, colorectal cancer, and colorectal cancer mortality: systematic review and meta-analysis. Front Oncol. 2022, 12:827019. 10.3389\/fonc.2022.827019","journal-title":"Front Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/nu13062101","article-title":"Visceral adiposity and Cancer: role in pathogenesis and prognosis","volume":"13","author":"Crudele L","year":"2021","unstructured":"Crudele L, Piccinin E, Moschetta A. Visceral adiposity and Cancer: role in pathogenesis and prognosis. Nutrients. 2021, 13:2101. 10.3390\/nu13062101","journal-title":"Nutrients"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.59652\/jsml.v2i2.199","article-title":"Studying the effect of some levels of fats in blood serum in patients with type 2 diabetes","volume":"2","author":"Ahmed FC","year":"2024","unstructured":"Ahmed FC, Hussein KM, Amir RAA, Affat PI. Studying the effect of some levels of fats in blood serum in patients with type 2 diabetes. J Sci Med Life. 2024, 2:199-205. 10.59652\/jsml.v2i2.199","journal-title":"J Sci Med Life"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020485","article-title":"Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and Management","volume":"15","author":"Pati S","year":"2023","unstructured":"Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and Management. Cancers (Basel). 2023, 15:485. 10.3390\/cancers15020485","journal-title":"Cancers (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.864263","article-title":"Metabolic diffusion in neuropathologies: the relevance of brain-liver axis","volume":"13","author":"Vegas-Su\u00e1rez S","year":"2022","unstructured":"Vegas-Su\u00e1rez S, Sim\u00f3n J, Mart\u00ednez-Chantar ML, Moratalla R. Metabolic diffusion in neuropathologies: the relevance of brain-liver axis. Front Physiol. 2022, 13:864263. 10.3389\/fphys.2022.864263","journal-title":"Front Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215268","article-title":"Metabolic pathways, enzymes, and metabolites: opportunities in cancer therapy","volume":"14","author":"Kumar R","year":"2022","unstructured":"Kumar R, Mishra A, Gautam P, et al.. Metabolic pathways, enzymes, and metabolites: opportunities in cancer therapy. Cancers (Basel). 2022, 14:10.3390\/cancers14215268","journal-title":"Cancers (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"Nordlinger B","year":"2013","unstructured":"Nordlinger B, Sorbye H, Glimelius B, et al.. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013, 14:1208-1215. 10.1016\/S1470-2045(13)70447-9","journal-title":"Lancet Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-019-00194-x","article-title":"Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles","volume":"10","author":"Qian S","year":"2019","unstructured":"Qian S, Golubnitschaja O, Zhan X. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA J. 2019, 10:365-381. 10.1007\/s13167-019-00194-x","journal-title":"EPMA J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01146","article-title":"Tumor-associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy","volume":"9","author":"Masucci MT","year":"2019","unstructured":"Masucci MT, Minopoli M, Carriero MV. Tumor-associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy. Front Oncol. 2019, 9:1146. 10.3389\/fonc.2019.01146","journal-title":"Front Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-200062659","article-title":"CD4+ T lymphocytes: a critical component of antitumor immunity","volume":"23","author":"Ostrand-Rosenberg S","year":"2005","unstructured":"Ostrand-Rosenberg S. CD4+ T lymphocytes: a critical component of antitumor immunity. Cancer Invest. 2005, 23:413-419. 10.1081\/CNV-200062659","journal-title":"Cancer Invest"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28536","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis","volume":"134","author":"Li MX","year":"2014","unstructured":"Li MX, Liu XM, Zhang XF, et al.. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer. 2014, 134:2403-2413. 10.1002\/ijc.28536","journal-title":"Int J Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181da7a31","article-title":"Elevated preoperative C-reactive protein predicts poor cancer-specific survival in patients undergoing resection for non-small cell lung cancer","volume":"5","author":"O'Dowd C","year":"2010","unstructured":"O'Dowd C, McRae LA, McMillan DC, Kirk A, Milroy R. Elevated preoperative C-reactive protein predicts poor cancer-specific survival in patients undergoing resection for non-small cell lung cancer. J Thorac Oncol. 2010, 5:988-992. 10.1097\/JTO.0b013e3181da7a31","journal-title":"J Thorac Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/477950-metabolic-and-inflammatory-markers-of-fatty-liver-as-associated-factors-of-hepatic-metastatic-spread-in-colorectal-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:34:53Z","timestamp":1779856493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/477950-metabolic-and-inflammatory-markers-of-fatty-liver-as-associated-factors-of-hepatic-metastatic-spread-in-colorectal-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.109707","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,26]]}}}